North Shore-LIJ

North Shore-LIJ inks ENT partnership

The North Shore-LIJ Health System has formed a “first on Long Island” clinical affiliation with ENT and Allergy Associates, an LLP treating over 70,000 monthly patients across New York and New Jersey. The union of one of the nation’s largest health systems – slated to be rechristened Northwell Health in January – and the private ear, nose and throat specialist known as ENTA, bridges community-based and academic healthcare and “ensures a continuum of services from…


The Debrief: Michael Dowling, CEO of what might have been Laudica Health

In healthcare administration, Michael Dowling has done it all. A 20-year veteran of the former North Shore-LIJ Health System, now Northwell Health, he’s been New York’s health and human services director and commissioner of the state’s Department of Social Services. He was a senior vice president at Empire Blue Cross/Blue Shield and even taught social policy at the Fordham University Graduate School of Social Services, where he was an assistant dean. A “young 66” come…


North Shore-LIJ to rebrand as Northwell Health

The North Shore-LIJ Health System made it official Monday, announcing a major rebranding effort that starts with a new name for New York State’s largest employer. As first reported by Innovate LI, the board of trustees of the iconic 21-hospital system is rechristening the system Northwell Health, a moniker that reflects the past and serves as a “beacon of our future,” according to President and CEO Michael Dowling. “It’s unique, simple and approachable,” Dowling said…


Insurance plan, acquisitions boost NS-LIJ financials

More patients, the acquisition of two new hospitals and increased revenue from its health-insurance subsidiary helped the North Shore-LIJ Health System record a strong fiscal performance over the first half of 2015. An earnings report issued this week by the Great Neck-based health system notes an operating income of $52.7 million for the six months ending June 30, up from $38.1 million over the first half of 2014. The system’s “Discussion and Analysis of Financial…


NS-LIJ docs to the rescue with new heart pump

North Shore-LIJ doctors saved the life of a 74-year-old patient late last month using a tiny motorized device – just approved by the FDA – that boosts heart function in patients who suffer what’s called cardiogenic shock following a heart attack. The device, the Impella RP, is billed as “the world’s smallest heart pump” by its maker, Abiomed of Danvers, Mass. The Impella received FDA approval in January. “Options that were available prior to this…


Taking North Shore-LIJ to market

By GREGORY ZELLER // With two spinoffs in play and as many as 10 waiting in the wings, the North Shore-LIJ Health System is ramping up its commercialization efforts at STAT speed. In particular, a series of ambitious collaborations between North Shore and the Cleveland Clinic – a nonprofit, multispecialty medical center melding hospital care with research and education – are beginning to bear commercial fruit. Speaking at a Long Island Association event on Thursday,…


Symbiotoc Health CEO Gerard Honig

Leading the fight against C. Diff

By GREGORY ZELLER // Researchers battling the insidious clostridium difficile infection are making progress on several new fronts, including a novel “poop pill” developed by Symbiotic Health, a spinoff from North Shore-LIJ’s Feinstein Institute. C. Diff, as it is known, is the most prevalent hospital-acquired infection in the United States and “an immediate public health threat,” according to the Centers for Disease Control. The infection attacks the gastrointestinal tract when broad-spectrum antibiotics fight off infections but…


Feinstein partnering with Australian pharma

The Feinstein Institute for Medical Research has inked a partnership deal with Novogen, an Australian pharmaceuticals giant and parent company of San Diego-based MEI Pharma, which produces a growing list of anti-cancer drugs already in the clinical stage. The collaboration is intended to develop new pharmaceutical treatments to battle brain cancers, which are currently treated by surgical removal, which traumatizes surrounding healthy brain tissue, and chemotherapy, which is limited by the brain’s natural defenses against…


CSHL's Bruce Stillman

North Shore-LIJ, CSHL in cancer partnership

Cold Spring Harbor Laboratory and North Shore-LIJ announced a joint cancer research and treatment effort that is designed to speed the region’s most-promising research to patients. The affiliation will better connect researchers at CSHL and North Shore’s Feinstein Institute for Medical Research and provide patients for clinical trials of the latest treatments, linking scieentists with more than 200 oncologists at North Shore-LIJ’s Cancer Institute. Cold Spring Harbor CEO Bruce Stillman called the paertnership a “transformative…


stuart rabinowitz

Hofstra, NS-LIJ nursing school unveiled

Hofstra University and the North Shore-LIJ Health System unveiled plans for a School of Graduate Nursing and Health Professions, with school officials saying the initial focus is on health care professionals already at work in the region. North Shore-LIJ spokesman Terry Lynam told Innovate-LI that the expectation is the student population of the new Hempstead school – jointly announced this week by Hofstra University and the ever-expanding health system – will be largely comprised of…